Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
Rigshospitalet, Denmark
Hospital Universitario Araba
Emory University
University Medical Center Groningen
Peking Union Medical College Hospital
Sanguine Biosciences
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Unither Pharmaceuticals, France
National Institutes of Health Clinical Center (CC)